Obelisk aims to advance our understanding of the molecular mechanisms contributing to or preventing childhood obesity. It seeks to develop tools for early prediction and prevention, identify new genes associated with childhood obesity, and explore targeted approaches for prevention. The project will also conduct a clinical study on an existing drug to reverse obesity in individuals with a genetic predisposition. Obelisk will disseminate best practices, educate others on preventing and treating childhood obesity, and collaborate with other initiatives to optimise knowledge and joint activities.
The project is built on a participatory approach, with engagement from families and carers, daycare providers and schools, local authorities, the healthcare industry, policymakers, and the scientific and academic communities.